Tag

Targeted Therapy

All articles tagged with #targeted therapy

Dismissed Cough, Determined Fight: A Young Non-Smoker's Stage 4 Lung Cancer Story
health2 months ago

Dismissed Cough, Determined Fight: A Young Non-Smoker's Stage 4 Lung Cancer Story

Heather Suchan, a non-smoker and mother of two, saw persistent coughs dismissed by doctors before a bronchoscopy confirmed Stage 4 non-small cell lung cancer with an EGFR mutation. After a PET scan revealed widespread disease, she underwent a multi-drug treatment plan including chemotherapy and a targeted drug amivantamab, now administered subcutaneously, which has led to no disease progression and regression of cancer in the liver and bones, allowing her to return to work while continuing treatment.

Non-smoker mom battles stage 4 alk-positive lung cancer and thrives
science2 months ago

Non-smoker mom battles stage 4 alk-positive lung cancer and thrives

A 44-year-old mom with no smoking history develops persistent breathlessness and is diagnosed with stage 4 alk-positive lung cancer. She responds to targeted therapies that block cancer growth, survives years beyond typical expectations, and becomes an advocate for alk-positive patients, highlighting how precision medicine can extend life and improve quality of life.

Breathless to Breakthrough: A Non-Smoking Mom Defies Stage 4 Lung Cancer
health3 months ago

Breathless to Breakthrough: A Non-Smoking Mom Defies Stage 4 Lung Cancer

Summer Farmen, a 44-year-old Pennsylvania mom with three kids, began experiencing severe breathlessness in early 2020 and was diagnosed with stage 4 alk-positive lung cancer—a rare, non-hereditary mutation highly treatable with targeted therapy. Though prognosis was grim, she has lived more than six years and become a patient advocate through Alk Positive Inc., funding research, leading support programs, and educating others about treatment options and clinical trials while continuing regular scans and treatment.

Precision drugs extend cancer survival, turning it into a chronic condition
health4 months ago

Precision drugs extend cancer survival, turning it into a chronic condition

Advances in targeted therapies and precision medicine are enabling more people to live with cancer longer, shifting the disease from an imminent death sentence to a chronic condition for many patients. While survival improves across cancers, the era of targeted drugs also highlights ongoing challenges around access, affordability, and managing long-term treatment effects.

KRAS-Targeting Pill Extends Survival in Metastatic Pancreatic Cancer
science4 months ago

KRAS-Targeting Pill Extends Survival in Metastatic Pancreatic Cancer

A KRAS-targeting pill called daraxonrasib nearly doubles median survival in metastatic pancreatic cancer, boosting it from 6.7 to 13.2 months in a 500-patient randomized trial after prior treatment, with fewer severe side effects; experts say it could become the new standard of care and researchers will study earlier use and KRAS subtypes. FDA expedited review and expanded-access programs are planned, and results were published in NEJM and presented at ASCO.

Eye trouble uncovers stage 4 lung cancer; endurance athlete defies odds with new therapies
health5 months ago

Eye trouble uncovers stage 4 lung cancer; endurance athlete defies odds with new therapies

A former Ironman triathlete’s vision problems led doctors to diagnose stage 4 lung cancer, and after a sequence of targeted therapies—including afatinib, osimertinib, and the IV drug amivantamab (Rybrevant)—he has lived seven years beyond an initial 12–24 month prognosis and now raises awareness through advocacy and endurance events.

Colorado man first in state to receive pioneering pancreatic cancer drug
health7 months ago

Colorado man first in state to receive pioneering pancreatic cancer drug

A Lafayette father with stage 4 pancreatic cancer is the first patient in Colorado to receive Zenocutuzumab, a newly FDA-approved targeted therapy that targets the tumor's NRG1 gene fusion after chemotherapy stopped working; since starting the drug, he has shown a dramatic response and improved quality of life, illustrating a broader shift toward precision medicine in pancreatic cancer that could extend survival for some patients.

Lung cancer shifts to younger, non-smoking women
health8 months ago

Lung cancer shifts to younger, non-smoking women

A growing share of lung cancer cases now occur in never-smokers, especially women, with radon exposure and other factors contributing to risk. Laura Hamann’s story illustrates this trend, often asymptomatic and found incidentally; advances in targeted therapies are improving outcomes, and experts urge radon testing and discussion of screening for high-risk individuals.

US hits 70% five-year cancer survival milestone
health9 months ago

US hits 70% five-year cancer survival milestone

New data from the American Cancer Society show seven in 10 U.S. cancer patients survive at least five years after diagnosis (based on 2015–2021 data), marking a historic milestone driven by advances like immunotherapy and targeted therapies, earlier detection, and reduced smoking; the report credits ongoing research for preventing thousands of deaths since the 1990s, but notes rising colorectal cancer rates in younger adults, persistent disparities, and concerns about funding cuts and screening disruptions that could affect future progress.

Mother of Two Mistakes Cancer Symptoms for Cold, Finds Widespread Disease
health11 months ago

Mother of Two Mistakes Cancer Symptoms for Cold, Finds Widespread Disease

Heather Quintana, a mother of two, initially thought her persistent cold was minor but was diagnosed with advanced Stage 4 lung cancer after a series of tests. She received targeted treatment and radiation, which significantly shrank her tumors, and emphasizes the importance of trusting healthcare providers over Dr. Google. Her story highlights the need for early detection and personalized treatment in cancer care.